Dr. Sulaiman Al Habib Medical Services Group Company Website

Dr. Sulaiman Al Habib Medical Services Group Company

SASE-4013

Company Overview

Dr. Sulaiman Al Habib Medical Services Group Company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities in Saudi Arabia. The company operates maternity, and orthopedics and spinal surgeries hospitals. It also operates dermatology, plastic surgery, ophthalmology, obesity treatment, and fertility centers, as well as pharmacies. In addition, the company provides home medical care, specialized medical laboratories, technology, information systems, and facility maintenance services, as well as medical equipment maintenance and telemedicine services. Dr. Sulaiman Al Habib Medical Services Group Company was founded in 1993 and is headquartered in Riyadh, Saudi Arabia.

  • Name

    Dr. Sulaiman Al Habib Medical Services Group Company

  • CEO

    Faisal Abdullah Ali Al-Nassar

  • Website

    www.hmg.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    1993

Profile

  • Market Cap

    SAR 107.87B

  • EV

    SAR 112.78B

  • Shares Out

    350M

  • Revenue

    SAR 10.02B

  • Employees

Margins

  • Gross

    34.42%

  • EBITDA

    24.69%

  • Operating

    21.89%

  • Pre-Tax

    22.68%

  • Net

    21.7%

  • FCF

    -10.43%

Returns (5Yr Avg)

  • ROA

    12.96%

  • ROTA

    25.71%

  • ROE

    25.71%

  • ROCE

    16.57%

  • ROIC

    18.04%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    SAR 302.67

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    SAR 1,341.09M

  • Net Debt

    SAR 4,602.04M

  • Debt/Equity

    0.84

  • EBIT/Interest

    29.84

Growth (CAGR)

  • Rev 3Yr

    14.03%

  • Rev 5Yr

    16.18%

  • Rev 10Yr

  • Dil EPS 3Yr

    19.94%

  • Dil EPS 5Yr

    21.1%

  • Dil EPS 10Yr

  • Rev Fwd 2Yr

    21.79%

  • EBITDA Fwd 2Yr

    21.64%

  • EPS Fwd 2Yr

    14.36%

  • EPS LT Growth Est

    17.73%

Dividends

  • Yield

  • Payout

    74.96%

  • DPS

    SAR 4.66

  • DPS Growth 3Yr

    21.47%

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    7.77%

SASE:4013